Mira IV Acquisition Corp. announces filing of filing statement

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW./

TORONTO, May 25, 2015 /CNW/ - Mira IV Acquisition Corp. ("Mira IV"; TSX Venture: MRY.P) is pleased to announce that it has received conditional acceptance from the TSX Venture Exchange (the "TSXV") in respect of its qualifying transaction (the "Transaction") with Profound Medical Inc. ("Profound") pursuant to Policy 2.4 - Capital Pool Companies of the TSXV.

In accordance with the previously announced amalgamation agreement dated April 29, 2015, Mira IV Subco Inc., a wholly-owned subsidiary of Mira IV, will amalgamate with Profound. The Transaction is expected to close on or about June 4, 2015.

Filing Statement

In connection with the Transaction and pursuant to TSXV requirements, Mira IV has filed a filing statement dated May 22, 2015 on SEDAR (www.sedar.com). 

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction.

ANY SECURITIES REFERRED TO HEREIN WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933 (THE "1933 ACT") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO A U.S. PERSON IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE 1933 ACT.

Notice regarding forward-looking statements:

This release includes forward-looking statements regarding Mira IV, Profound and their respective businesses, which may include, but is not limited to, statements with respect to the completion of the Transaction, the ability to obtain regulatory approvals and other factors. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity. The forward-looking events and circumstances discussed in this release, including completion of the Transaction, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including risks regarding the pharmaceutical industry, failure to obtain regulatory or shareholder approvals, economic factors, the equity markets generally and risks associated with growth and competition. Although Mira IV and Profound have attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Mira IV and Profound undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

SOURCE Mira IV Acquisition Corp.

concerning Mira IV Acquisition Corp., please contact: Jordan Kupinsky, Director, Tel: [phone], Fax: [phone]; For further information concerning Profound Medical Inc., please contact: Steven Plymale, Chief Executive Officer, Tel: [phone], Fax: [phone]